Terumo Cardiovascular Systems Corporation recalls Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- During some clinical cases, it has been observed that the SO2 value may periodically appear as dashes on the Touchscreen Display indicating unavailable data. In these cases, a yellow low-limit alarm will also be triggered to the user, due to the dashed-out value.
- Products
-
- Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe
- Where it was sold
-
US: IL, TX, NY, MI, FL, NV, and Australia, New Zealand
States: Florida, Illinois, Michigan, Nevada, New York, Texas
- Barcodes
00886799001882- Units affected
- 37 units
- About this recall
- Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754